Safety and efficacy of AG-221, a potent inhibitor of mutant IDH2 that promotes differentiation of myeloid cells in patients with advanced hematologic malignancies: Results of a phase 1/2 trial Meeting Abstract

  

Authors:	Stein, E. M.; DiNardo, C.; Altman, J. K.; Collins, R.; DeAngelo, D. J.; Kantarjian, H. M.; Sekeres, M. A.; Fathi, A. T.; Flinn, I. W.; Frankel, A. E.; Levine, R. L.; Medeiros, B. C.; Patel, M. R.; Pollyea, D.; Roboz, G. J.; Stone, R. M.; Swords, R. T.; Tallman, M. S.; Yen, K.; Attar, E. C.; Xu, Q.; Tosolini, A.; Mei, J. M.; Thakurta, A.; Knight, R. D.; De Botton, S.
Abstract Title:	Safety and efficacy of AG-221, a potent inhibitor of mutant IDH2 that promotes differentiation of myeloid cells in patients with advanced hematologic malignancies: Results of a phase 1/2 trial
Meeting Title:	57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	126
Issue:	23
Meeting Dates:	2015 Dec 5-8
Meeting Location:	Orlando, FL
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2015-12-03
Language:	English
ACCESSION:	WOS:000368019001075
PROVIDER:	wos
DOI:	10.1182/blood.V126.23.323.323
Notes:	Meeting Abstract: 323 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/91480